BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34474543)

  • 1. Primary cutaneous CD4+ small/medium T-cell lymphoma: a case report.
    Kim J; Jeong M; Jun D; Lee M; Shin D; Kim W; Choi H
    Arch Craniofac Surg; 2021 Aug; 22(4):199-203. PubMed ID: 34474543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Cutaneous CD4
    Maurelli M; Colato C; Gisondi P; Girolomoni G
    J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up and management of small and medium-sized CD4
    Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
    Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous CD4
    Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous CD4+ small-/medium-sized T-cell lymphoproliferative disorder: A case report.
    Koper M; Putała-Pośpiech M; Biernat W; Woźniacka A; Robak E
    Clin Case Rep; 2019 Apr; 7(4):703-706. PubMed ID: 30997068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
    Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination-What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature.
    De la Torre-Gomar FJ; Llamas-Molina JM; Pegalajar-García MD; Pérez-Valencia C; Carrero-Castaño A; Ruiz-Villaverde R
    Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment.
    Gru AA; Wick MR; Eid M
    Semin Cutan Med Surg; 2018 Mar; 37(1):39-48. PubMed ID: 29719019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report.
    Dimassi AB; Howlett C; Phua CW
    Cureus; 2020 Jun; 12(6):e8534. PubMed ID: 32665881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.
    Keeling BH; Gavino ACP; Admirand J; Soldano AC
    J Cutan Pathol; 2017 Nov; 44(11):944-947. PubMed ID: 28749588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.
    Alberti-Violetti S; Torres-Cabala CA; Talpur R; Corti L; Fanoni D; Venegoni L; Berti E; Duvic M
    J Cutan Pathol; 2016 Dec; 43(12):1121-1130. PubMed ID: 27550169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Longer Cutaneous T-cell Lymphoma Dermal Nodule.
    Yousif ML; Zhao X; Andrews D
    Cureus; 2023 Dec; 15(12):e50796. PubMed ID: 38239551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis.
    Wang L; Wang G; Gao T
    J Cutan Pathol; 2015 Apr; 42(4):265-70. PubMed ID: 25407448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder.
    Hong Q; Li J; Li F; Lu L; Su J; Chen M
    Indian J Dermatol; 2023; 68(5):551-553. PubMed ID: 38099110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
    James E; Sokhn JG; Gibson JF; Carlson K; Subtil A; Girardi M; Wilson LD; Foss F
    Leuk Lymphoma; 2015 Apr; 56(4):951-7. PubMed ID: 24996443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
    Toberer F; Hartschuh W; Hadaschik E
    JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Richter Syndrome Mimicking Primary Cutaneous CD4-Positive Small/Medium T-cell Lymphoma: Case Report and Review of the Literature.
    Rito M; Cabeçadas J; Costa Rosa J; Cravo M; Robson A
    Am J Dermatopathol; 2018 Apr; 40(4):286-290. PubMed ID: 28937430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurolymphomatosis in Primary Cutaneous CD4+ Pleomorphic Small/Medium-sized T-cell Lymphoma Mimicking Hansen's Disease.
    Khader A; Vineetha M; George M; Manakkad SP; Balakrishnan S; Rajan U
    Indian J Dermatol; 2017; 62(3):315-317. PubMed ID: 28584377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
    Williams VL; Torres-Cabala CA; Duvic M
    Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.